FDA Inspection
Bayer AGBayer AG – FDA Inspection, Mar 10, 2009
Record Details
This FDA Inspection record concerns Bayer AG, with an inspection on March 10, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bayer AG
- Inspection Date
- March 10, 2009
- Product Type
- Drugs
View Company Profile
ID · 9c38b2d3-0a4b-4374-95c5-d1479cc0377b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 573369
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bayer AG
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 10, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bayer AG
- FDA Inspection 1282946 - 2024-11-14
- FDA Inspection 1126224 - 2019-10-10
- FDA Inspection 1062335 - 2018-06-15
- FDA Inspection 949853 - 2015-11-12
- FDA Inspection 837370 - 2013-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.